Impaired intracellular trafficking defines early Parkinson's disease
about
There's Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative DiseasesMembrane remodeling and mechanics: Experiments and simulations of α-SynucleinConverging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's diseaseSynaptopathies: synaptic dysfunction in neurological disorders - A review from students to studentsEnteric neurons from Parkinson's disease patients display ex vivo aberrations in mitochondrial structure.Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson's disease.Aldehyde dehydrogenase 1-positive nigrostriatal dopaminergic fibers exhibit distinct projection pattern and dopamine release dynamics at mouse dorsal striatum.Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?Genetic variants in GAPDH confer susceptibility to sporadic Parkinson's disease in a Chinese Han population.The ESCRT regulator Did2 maintains the balance between long-distance endosomal transport and endocytic traffickingα-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.Variant U1 snRNAs are implicated in human pluripotent stem cell maintenance and neuromuscular disease.The Synucleinopathies: Twenty Years On.Autophagy in synaptic development, function, and pathology.Basic science breaks through: New therapeutic advances in Parkinson's disease.Reduced expression of PARK2 in manganese-exposed smelting workers.Review: Parkinson's disease: from synaptic loss to connectome dysfunction.Synaptic failure and α-synuclein.Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.Early synaptic dysfunction in Parkinson's disease: Insights from animal models.Calcium and Parkinson's disease.Microtubule Destabilization Paves the Way to Parkinson's Disease.In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons.Selective neuronal vulnerability in Parkinson disease.Transcriptome Profile Changes in Mice with MPTP-Induced Early Stages of Parkinson's Disease.Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease.The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging.Omics Approaches for Identifying Physiological Adaptations to Genome Instability in Aging.The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease.Parkinson's Disease Is Not Simply a Prion Disorder.Convergent pathways in Parkinson's disease.Parkinson's Disease, the Dopaminergic Neuron and Gammahydroxybutyrate.Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy.Minimotifs dysfunction is pervasive in neurodegenerative disorders
P2860
Q26768635-804529B0-2690-43C8-9BA2-28F9F820EEDFQ28066666-87A5921B-93B2-4446-AF65-224ACE1D237CQ28074143-17730EF9-69AD-4946-93D2-D43912AC9AD6Q28077671-0A04F5F0-31C2-4E49-8AE3-61D58B663199Q30810965-E2C1A38A-B990-4F81-BC4E-A71F76BEC4AAQ33819127-2C39BF29-D712-40AB-A10A-4BE6D57D4E1DQ33902847-E07C7D4B-6CCC-431B-8D17-B8AE39B1D708Q35412397-B60AD920-7785-4E96-BB68-9E43A2FF7952Q35741353-ED0F7053-DE1C-4E0A-8F26-F6C69F352E27Q36350818-0CA31932-D47B-41C3-9CC2-8216C9F29BA0Q36607556-5E9AD6A5-EA22-44FD-8CC9-3F16468AAC31Q37507550-ACFA2ADB-CD26-45CB-BC45-A3329C8AD33BQ37693375-54ABADD9-5340-4492-91A6-88A120FAF952Q38542336-435F8A99-4895-47B4-8D8A-427843F14FCEQ38547662-6B2AEEB1-F386-4F9D-A0B4-8C7664A8C906Q38615741-126A2846-A3D7-42E2-B424-6DE04A3C1DD9Q38650395-A21A8EA7-4108-4B72-9EC5-4F513B944EA6Q38704236-EA7A9F8C-28F5-4D15-9C3B-83835CB793F4Q38730062-D7AC8B8F-AB50-46A4-877D-4A7B23E7DBF7Q38837604-9A23555E-663C-4608-A2D1-724C4AEF3975Q38945252-F122890F-21CE-429E-86D0-BF4954803D2DQ38984991-3655A414-6077-4541-BD28-054F6696777AQ38993636-C9B717AC-34CB-4FE9-B1BD-7CBBF2C20B14Q39095738-71F7A5EB-875A-4127-963E-A1F8A60BD6D1Q39273083-4A708CE8-10E3-4CA9-ACE5-E46B6B613F3EQ40108542-CF02240B-4128-4B0C-8617-D581601D6878Q41664833-4963090B-D302-445A-9BA8-44DA75C3F252Q42213761-291C6935-E15D-4666-80C7-76CB5725850AQ42700405-EDA9DB7E-EED1-4AD5-83FE-E2F0B4B67855Q47097416-4606420A-6889-4C18-9ECA-3891EAA8D256Q47217972-45B1657F-6162-40C3-BF0F-90B47030A4A6Q47314960-129CBF55-85FB-49AC-B4F3-03A5BC0357C2Q47612330-547D2583-DF8A-4E21-8E2B-7FBBEF052AC6Q47640970-CB75DE89-3ECE-4316-8958-D47F3CBF5D66Q48165108-00DBF2A7-A3E3-458D-8838-2BA4C89EF163Q51736398-CE76C042-1E3C-41BE-BFBD-4F22850DDE56Q57174649-5C9066DE-7191-46F2-9CC8-5382A6B13FC4
P2860
Impaired intracellular trafficking defines early Parkinson's disease
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Impaired intracellular trafficking defines early Parkinson's disease
@en
type
label
Impaired intracellular trafficking defines early Parkinson's disease
@en
prefLabel
Impaired intracellular trafficking defines early Parkinson's disease
@en
P2860
P50
P921
P1476
Impaired intracellular trafficking defines early Parkinson's disease
@en
P2093
Maria-Grazia Spillantini
P2860
P304
P356
10.1016/J.TINS.2014.12.009
P5008
P577
2015-01-29T00:00:00Z